Loading…
Patient Risk Interpretation of Symptoms Model (PRISM): How Patients Assess Cardiac Risk
Background While there is a prevailing perception that coronary artery disease (CAD) is a “man’s disease,” little is known about the factors which influence cardiac risk assessment and whether it varies by gender. Objectives 1) Qualitatively capture the complexity of cardiac risk assessment from a p...
Saved in:
Published in: | Journal of general internal medicine : JGIM 2021-08, Vol.36 (8), p.2205-2211 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background
While there is a prevailing perception that coronary artery disease (CAD) is a “man’s disease,” little is known about the factors which influence cardiac risk assessment and whether it varies by gender.
Objectives
1) Qualitatively capture the complexity of cardiac risk assessment from a patient-centered perspective. 2) Explore how risk assessment may vary by gender. 3) Quantitatively validate qualitative findings among a new sample.
Design
This study was conducted in two parts: (1) semi-structured in-depth interviews were audio-recorded, transcribed verbatim, and analyzed using modified grounded theory; (2) emergent themes were surveyed in a separate sample to validate findings quantitatively. Differences were estimated using 2-tailed
t
-tests and kappa.
Participants
Participants who were referred for their first elective coronary angiogram for suspected CAD with at least 1 prior abnormal test were recruited from a tertiary care hospital.
Main Measures
Patient-centered themes were derived from part one. In part two, patients estimated the probability that their symptoms were heart-related at multiple time points.
Results
Part 1 included 14 men and 17 women (mean age=63.3±11.8 years). Part 2 included 237 patients, of which 109 (46%) were women (mean age=66.0±11.3 years). Part 1 revealed that patients’ risk assessment evolves in three distinct phases, which were captured using an Ishikawa framework entitled “Patient Risk Interpretation of Symptoms Model” (PRISM). Part 2 validated PRISM findings; while patients were more likely to attribute their symptoms to CAD over time (phase 1 vs. 3: 21% vs. 73%,
p |
---|---|
ISSN: | 0884-8734 1525-1497 |
DOI: | 10.1007/s11606-021-06770-0 |